The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5
Open accessAbstract
Hyperphosphorylation of microtubule-associated proteins such as tau and neurofilament may underlie the cytoskeletal abnormalities and neuronal death seen in several neurodegenerative diseases including Alzheimer's disease. One potential mechanism of microtubule-associated protein hyperphosphorylation is augmented activity of protein kinases known to associate with microtubules, such as cdk5 or GSK3β. Here we show that tau and neurofilament are hyperphosphorylated in transgenic mice that overexpress human p25, an activator of cdk5. The p25 transgenic mice display silver-positive neurons using the Bielschowsky stain. Disturbances in neuronal cytoskeletal organization are apparent at the ultrastructural level. These changes are localized predominantly to the amygdala, thalamus/hypothalamus, and cortex. The p25 transgenic mice display increased spontaneous locomotor activity and differences from control in the elevated plus-maze test. The overexpression of an activator of cdk5 in transgenic mice results in increased cdk5 activity that is sufficient to produce hyperphosphorylation of tau and neurofilament as well as cytoskeletal disruptions reminiscent of Alzheimer's disease and other neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In transgenic mice, expression of the CDK5 activator p25 ( Ahlijanian et al. 2000), CDK5together with p25 ( Noble et al. 2003), a dominant negative form of PP2A ( Kins et al. 2001), or GSK3 ( Spittaels et al. 2000; Lucas et al. 2001) results in hyperphosphorylation of Tau, but effects on neurodegenerative cell death have been variable.”
From Genetic modifiers of tauopathy in Drosophila (2003) · cites this paper as Ahlijanian et al. 2000
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Manipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
The use of a plus-maze to measure anxiety in the mouse
Lister, R. (1987) · Psychopharmacology · doi:10.1007/bf00177912 · Cited by 2,609
Manipulating the Mouse Embryo: A Laboratory Manual
Behringer, R. R., Gertsenstein, M., Nagy, K. V., & Nagy, A. (2002) · Cited by 2,046
Irwin, S. (1968) · Psychopharmacologia · doi:10.1007/bf00401402 · Cited by 1,234
Sternberger, L. A., & Sternberger, N. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.6126 · Cited by 1,158
p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5
Tsai, L.-H., Delalle, I., Caviness, V. S., Chae, T., & Harlow, E. (1994) · Nature · doi:10.1038/371419a0 · Cited by 922
Bramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903
Ohshima, T., Ward, J. M., Huh, C. G., Longenecker, G., Veeranna, Pant, H. C., Brady, R. O., Martin, L. J., & Kulkarni, A. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11173 · Cited by 894
Biernat, J., Gustke, N., Drewes, G., Mandelkow, E., & Mandelkow, E. (1993) · Neuron · doi:10.1016/0896-6273(93)90279-z · Cited by 796
Braak, F., Braak, H., & Mandelkow, E. M. (1994) · Acta Neuropathologica · doi:10.1007/bf00293315 · Cited by 772
Chae, T., Kwon, Y. T., Bronson, R., Dikkes, P., Li, E., & Tsai, L.-H. (1997) · Neuron · doi:10.1016/s0896-6273(01)80044-1 · Cited by 715
A brain-specific activator of cyclin-dependent kinase 5
Lew, J., Huang, Q.-Q., Qi, Z., Winkfein, R. J., Aebersold, R., Hunt, T., & Wang, J. H. (1994) · Nature · doi:10.1038/371423a0 · Cited by 579
Biernat, J., Mandelkow, E. M., Schröter, C., Lichtenberg‐Kraag, B., Steiner, B., Berling, B., Meyer, H., Mercken, M., Vandermeeren, A., & Goedert, M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05204.x · Cited by 484
Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system
Tsai, L.-H., Takahashi, T., Caviness, V. S., & Harlow, E. (1993) · Development · doi:10.1242/dev.119.4.1029 · Cited by 457
Götz, J., Probst, A., Spillantini, M. G., Schäfer, T., Jakes, R., Bürki, K., & Goedert, M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07116.x · Cited by 439
The Structural Basis of Monoclonal Antibody Alz50's Selectivity for Alzheimer's Disease Pathology
Carmel, G., Mager, E. M., Binder, L. I., & Kuret, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32789 · Cited by 402
LoPresti, P., Szuchet, S., Papasozomenos, S. C., Zinkowski, R. P., & Binder, L. I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10369 · Cited by 388
Forss-Petter, S., Danielson, P. E., Catsicas, S., Battenberg, E., Price, J., Nerenberg, M., & Sutcliffe, G. (1990) · Neuron · doi:10.1016/0896-6273(90)90308-3 · Cited by 365
An Isoform of the Neuronal Cyclin-dependent Kinase 5 (Cdk5) Activator
Tang, D., Yeung, J., Lee, K.-Y., Matsushita, M., Matsui, H., Tomizawa, K., Hatase, O., & Wang, J. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26897 · Cited by 340
Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
Imahori, K., & Uchida, T. (1997) · PubMed · Cited by 288
Paudel, H. K., Lew, J., Ali, Z., & Wang, J. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49492-1 · Cited by 285
Tau Mutations Cause Frontotemporal Dementias
Goedert, M., Crowther, R. A., & Spillantini, M. G. (1998) · Neuron · doi:10.1016/s0896-6273(00)80615-7 · Cited by 268
Wagner, U., Utton, M., Gallo, J.-M., & Miller, C. C. J. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.6.1537 · Cited by 254
Ishiguro, K., Takamatsu, M., Tomizawa, K., Omori, A., Takahashi, M., Arioka, M., Uchida, T., & Imahori, K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50102-8 · Cited by 247
Matsubara, M., Kusubata, M., Ishiguro, K., Uchida, T., Titani, K., & Taniguchi, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.21108 · Cited by 241
Szendrei, G. I., Lee, V. M. ‐., & Otvos, L. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490340212 · Cited by 200
Brion, J.-P., Tremp, G., & Octave, J.-N. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65272-8 · Cited by 197
Burns, L. H., Annett, L., Kelly, A. E., Everitt, B. J., & Robbins, T. W. (1996) · Behavioral Neuroscience · doi:10.1037//0735-7044.110.1.60 · Cited by 196
Hoffmann, R., Lee, V. M. ‐., Leight, S., Varga, I., & Ötvös, L. (1997) · Biochemistry · doi:10.1021/bi970380+ · Cited by 182
Ksiezak-Reding, H., Dickson, D. W., Davies, P., & Yen, S. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3410 · Cited by 180
Regulation of Munc-18/Syntaxin 1A Interaction by Cyclin-dependent Kinase 5 in Nerve Endings
Shuang, R., Zhang, L., Fletcher, A., Groblewski, G. E., Pevsner, J., & Stuenkel, E. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.4957 · Cited by 161
Voltage-Gated K+Channel β Subunits: Expression and Distribution of Kvβ1 and Kvβ2 in Adult Rat Brain
Rhodes, K. J., Monaghan, M. M., Barrezueta, N. X., Nawoschik, S. P., Bekele-Arcuri, Z., Matos, M. F., Nakahira, K., Schechter, L. E., & Trimmer, J. S. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-16-04846.1996 · Cited by 157
Self-citationPhosphorylation of the High Molecular Weight Neurofilament Protein (NF-H) by Cdk5 and p35
Sun, D., Leung, C. L., & Liem, R. K. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14245 · Cited by 154
Arendt, T., Holzer, M., Fruth, R., Brückner, M. K., & Gärtner, U. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00347-l · Cited by 139
Cytoskeletal Changes in the Brains of Mice Lacking Calcineurin Aα
Kayyali, U. S., Zhang, W., Yee, A. G., Seidman, J. G., & Potter, H. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68041668.x · Cited by 110
Fix, A. S., Ross, J. F., Stitzel, S. R., & Switzer, R. C. (1996) · Toxicologic Pathology · doi:10.1177/019262339602400305 · Cited by 109
Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3β transgenes
Brownlees, J., Irving, N. G., Brion, J., Gibb, B. J. M., Wagner, U., Woodgett, J. R., & Miller, C. C. J. (1997) · Neuroreport · doi:10.1097/00001756-199710200-00013 · Cited by 99
Abnormal processing of multiple proteins in Alzheimer disease.
Zhang, H., Sternberger, N. H., Rubinstein, L. J., Herman, M. M., Binder, L. I., & Sternberger, L. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.8045 · Cited by 96
Michel, G., Mercken, M., Murayama, M., Noguchi, K., Ishiguro, K., Imahori, K., & Takashima, A. (1998) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(97)00139-6 · Cited by 92
Glial fibrillary acidic protein immunoreactivity in normal and diseased human breast
Viale, G., Gambacorta, M., Coggi, G., Dell’Orto, P., Milani, M., & Doglioni, C. (1991) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01600164 · Cited by 76
Evidence for cdk5 as a Major Activity Phosphorylating Tau Protein in Porcine Brain Extract1
Hosoi, T., Uchiyama, M., Okumura, E., Saito, T., Ishiguro, K., Uchida, T., Okuyama, A., Kishimoto, T., & Hisanaga, S. (1995) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a124771 · Cited by 66
Neuronal Cdc2-like kinase: from cell cycle to neuronal function
Tang, D., Matsuura, I., Wang, J. H.-C., Lee, K.-Y., & Qi, R. Z. (1996) · Biochemistry and Cell Biology · doi:10.1139/o96-046 · Cited by 35
James, N. D., Davis, D. R., Sindon, J., Hanger, D. P., Brion, J., Miller, C. C. J., Rosenberg, M. P., Anderton, B. H., & Propst, F. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02068-3 · Cited by 28
Neuropathological Diagnosis of Dementia Using Silver Stains and Immunohistochemical Techniques
Powers, R. E., & Wilson, D. (1996) · Journal of Histotechnology · doi:10.1179/014788896794730559 · Cited by 2
Cited by
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174
Dhavan, R., & Tsai, L.-H. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096019 · Cited by 1,058
Chishti, M. A., Yang, D.-S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100710200 · Cited by 955
Molecular mechanisms of neurodegeneration in Alzheimer's disease
Crews, L., & Masliah, E. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq160 · Cited by 772
Metadata
- Authors
- Ahlijanian, M. K., Barrezueta, N. X., Williams, R. D., Jakowski, A., Kowsz, K. P., McCarthy, S., Coskran, T., Carlo, A., Seymour, P. A., Burkhardt, J. E., Nelson, R. B., & McNeish, J. D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-03-07
- Volume
- 97
- Issue
- 6
- Pages
- 2910-2915
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2112047897
- Cited by
- 341
- References
- 47
- FWCI
- 17.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.